REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,712,748 | +228.8% | 26,606 | -15.0% | 0.01% | +350.0% |
| Q4 2021 | $825,000 | -68.2% | 31,294 | +21.4% | 0.00% | -75.0% |
| Q3 2021 | $2,594,000 | -38.9% | 25,784 | -14.0% | 0.01% | -42.9% |
| Q2 2021 | $4,244,000 | +114.0% | 29,988 | +50.8% | 0.01% | +100.0% |
| Q1 2021 | $1,983,000 | -15.2% | 19,890 | +5.2% | 0.01% | -12.5% |
| Q4 2020 | $2,338,000 | +10.9% | 18,915 | -12.6% | 0.01% | 0.0% |
| Q3 2020 | $2,109,000 | -18.7% | 21,647 | +30.2% | 0.01% | -27.3% |
| Q2 2020 | $2,594,000 | +24.2% | 16,625 | +14.9% | 0.01% | +10.0% |
| Q1 2020 | $2,089,000 | -29.4% | 14,474 | 0.0% | 0.01% | -9.1% |
| Q4 2019 | $2,959,000 | – | 14,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |